Immune checkpoint is one of the targets of immunotherapy, including PD-1/PD-L1, CTLA-4, etc. PD-1 expresses on the surface of immune cells such as CD8+ T cells and CD4+ T cells, while PD-L1 expresses on the surface of APCs such as tumor cells and TAMs. This evidence concerns the gene CD274 and neoplasm.